Since METCAM/MUC18 promotes both the progression of prostate cancer and breast cancer cells, we anticipate that up-regulation of METCAM/MUC18 may increase expression of similar downstream key parameters during the progression of breast cancer cells. The gene discussed is MCAM; the disease is Familial prostate cancer.